UFP Technologies, Inc. designs and converts foams, films, and plastics materials for the medical, automotive, consumer, electronics, industrial, and aerospace and defense markets in the United States. It offers single patient use surfaces, advanced wound care, infection prevention, and disposables for surgical procedures, endoscopic procedures, orthopedic implants, orthopedic appliances, biopharma drug manufacturing, etc.; molded components for automotive, aerospace, and defense markets; recycled protective packaging for B2C brands; and reusable cases and custom inserts. The company markets and sells its products through direct sales forces and independent manufacturer representatives. UFP Technologies, Inc. was founded in 1963 and is headquartered in Newburyport, Massachusetts.
IPO Year: 1993
Exchange: NASDAQ
Website: ufpt.com
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 3/28/2025 | Mkt Perform | Raymond James | |
| 7/17/2024 | $344.00 → $392.00 | Buy | Lake Street |
| 3/20/2024 | Market Outperform | CJS Securities | |
| 2/6/2024 | Sector Weight | KeyBanc Capital Markets | |
| 12/21/2022 | $124.00 | Buy | Lake Street |
| 6/22/2022 | $110.00 | Buy | Lake Street |
| 11/19/2021 | $81.00 | Buy | Colliers Securities |
Fastest customizable press release news feed in the world
NEWBURYPORT, Mass., Aug. 20, 2025 (GLOBE NEWSWIRE) -- UFP Technologies, Inc. (UFPT), today announced Mitch Rock, President, and Ron Lataille, Sr. VP and CFO, will present at the Midwest IDEAS Investor Conference on Tuesday, August 26, 2025, at The InterContinental in Chicago, IL. UFP's presentation is scheduled to begin at 7:55 AM CT. The presentation is webcast and can be accessed through the conference host's main website: https://www.threepartadvisors.com/midwest and in the Investor Relations section of the company's website: http://www.ufpt.com. About IDEAS Investor Conferences The mission of the IDEAS Conferences is to provide independent regional venues for quality companies to pre
NEWBURYPORT, Mass., Aug. 04, 2025 (GLOBE NEWSWIRE) -- UFP Technologies, Inc. (NASDAQ:UFPT), a contract development and manufacturing organization that specializes in single-use and single-patient medical devices, today reported net income of $17.2 million or $2.21 per diluted common share outstanding for its second quarter ended June 30, 2025, compared to net income of $13.6 million or $1.75 per diluted common share outstanding for the same quarter in 2024. Adjusted earnings per diluted common share outstanding grew 27% to $2.50. Sales for the second quarter were $151.2 million compared to sales of $110.2 million in the second quarter of 2024. Net income for the six-month period ended June
NEWBURYPORT, Mass., July 29, 2025 (GLOBE NEWSWIRE) -- UFP Technologies, Inc. (NASDAQ:UFPT), a contract development and manufacturing organization that specializes in single-use and single-patient medical devices, today announced the Company plans to report financial results for the second quarter ended June 30, 2025 on August 4, 2025 after the market close. The Company will hold a conference call to discuss results the following day, August 5th, at 8:30 AM Eastern time. Conference Call Information:Date: Tuesday, August 5, 2025Time: 8:30 AM Eastern TimeParticipants may join the call using the following dial-in numbers: Toll-Free: 1-888-243-4451International: 1-412-542-4135 A live
LANCASTER, Pa., July 29, 2025 /PRNewswire/ -- Trout Capital Advisors, LLC ("TCA"), a leading lower-middle market investment banking firm, is pleased to announce it served as the exclusive financial advisor to Universal Plastics & Engineering Company, Inc. ("UNIPEC") in its sale to UFP Technologies, Inc. (NASDAQ:UFPT), a designer and manufacturer of innovative custom-engineered components, products, and solutions for the medical market. Headquartered in Rockville, Maryland, UNIPEC develops and manufactures precision thermoformed and heat-sealed polymer components used primarily for shielding batteries in Class III implantable medical devices. UNIPEC's capabilities and strong customer relatio
NEWBURYPORT, Mass., July 17, 2025 (GLOBE NEWSWIRE) -- UFP Technologies, Inc. (NASDAQ:UFPT), a designer and custom manufacturer of comprehensive solutions for medical devices, sterile packaging, and other highly engineered custom products, today announced the acquisitions of Universal Plastics & Engineering Company, Inc. ("UNIPEC") and Techno Plastics Industries, Inc. ("TPI"). These transactions further expand UFP's capabilities in tight tolerance film components and thermoplastic molding for the medical device market. UNIPEC, headquartered in Rockville, Maryland, develops and manufactures precision thermoformed and heat-sealed polymer components used primarily for shielding batteries in C
NEWBURYPORT, Mass., July 08, 2025 (GLOBE NEWSWIRE) -- UFP Technologies, Inc. (NASDAQ:UFPT), today announced that Mitchell Rock, President, and Ron Lataille, Sr. Vice President & CFO, will present and host 1x1 meetings at the CJS Securities 25th Annual Summer Conference on Thursday, July 10, 2025. About UFP Technologies, Inc. UFP Technologies is a contract development and manufacturing organization (CDMO) specializing in single-use, polymer-based medical devices and components. We help leading medical device companies deliver better patient outcomes at lower costs, partnering with them to design and manufacture new devices that they increasingly outsource. Our differentiated materials pla
NEWBURYPORT, Mass., June 03, 2025 (GLOBE NEWSWIRE) -- UFP Technologies (UFPT), today announced Jeffrey Bailly, Chairman and CEO and Ron Lataille, Sr. Vice President & CFO, will present at the East Coast IDEAS Investor Conference on Wednesday, June 11, 2025 at The Westin Times Square in New York, NY. UFP's presentation is scheduled to begin at 7:55 AM ET. The presentation is webcast and can be accessed through the conference host's main website: https://www.threepartadvisors.com/east-coast and in the investor relations section of the company's website: http://www.UFPT.com. About IDEAS Investor Conferences The mission of the IDEAS Conferences is to provide independent regional venues f
NEWBURYPORT, Mass., June 03, 2025 (GLOBE NEWSWIRE) -- UFP Technologies, Inc. (NASDAQ:UFPT), today announced that Jeffrey Bailly, Chairman and CEO, and Ron Lataille, Sr. Vice President & CFO, will present at the Goldman Sachs 46th Annual Global Healthcare Conference on Monday, June 9, 2025. UFP's fireside chat is scheduled to begin at 11:20 AM ET. About UFP Technologies, Inc. UFP Technologies is a designer and custom manufacturer of comprehensive solutions for medical devices, sterile packaging, and other highly engineered custom products. UFP is an important link in the medical device supply chain and a valued outsourcing partner to many of the top medical device manufacturers in the wor
NEWBURYPORT, Mass., May 06, 2025 (GLOBE NEWSWIRE) -- UFP Technologies, Inc. (NASDAQ:UFPT), a designer and custom manufacturer of comprehensive solutions primarily for the medical market, today reported net income of $17.2 million or $2.21 per diluted common share outstanding for its first quarter ended March 31, 2025, compared to net income of $12.7 million or $1.64 per diluted common share outstanding for the first quarter of 2024. Net Sales for the first quarter were $148.1 million compared to 2024 first quarter sales of $105.0 million. Throughout this news release, reference is made to non-GAAP measures including organic sales growth, adjusted operating income, adjusted SG&A, adjusted n
NEWBURYPORT, Mass., April 30, 2025 (GLOBE NEWSWIRE) -- UFP Technologies, Inc. (NASDAQ:UFPT), an innovative designer and custom manufacturer of components for medical devices, sterile packaging, and other highly engineered products, today announced the Company plans to report financial results for the first quarter ended March 31, 2025 on May 6, 2025 prior to market open. The Company will hold a conference call to discuss results the same day at 10:00 AM Eastern time. Conference Call Information:Date: Tuesday, May 6, 2025Time: 10:00 AM Eastern TimeParticipants may join the call using the following dial-in numbers: Toll-Free: 1-888-243-4451International: 1-412-542-4135 A live webcast of t
Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.
Raymond James initiated coverage of UFP Technologies with a rating of Mkt Perform
Lake Street reiterated coverage of UFP Technologies with a rating of Buy and set a new price target of $392.00 from $344.00 previously
CJS Securities initiated coverage of UFP Technologies with a rating of Market Outperform
KeyBanc Capital Markets initiated coverage of UFP Technologies with a rating of Sector Weight
Lake Street resumed coverage of UFP Technologies with a rating of Buy and set a new price target of $124.00
Lake Street initiated coverage of UFP Technologies with a rating of Buy and set a new price target of $110.00
Colliers Securities initiated coverage of UFP Technologies with a rating of Buy and set a new price target of $81.00
Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.
4 - UFP TECHNOLOGIES INC (0000914156) (Issuer)
4 - UFP TECHNOLOGIES INC (0000914156) (Issuer)
4 - UFP TECHNOLOGIES INC (0000914156) (Issuer)
Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.
4 - UFP TECHNOLOGIES INC (0000914156) (Issuer)
4 - UFP TECHNOLOGIES INC (0000914156) (Issuer)
4 - UFP TECHNOLOGIES INC (0000914156) (Issuer)
4 - UFP TECHNOLOGIES INC (0000914156) (Issuer)
4 - UFP TECHNOLOGIES INC (0000914156) (Issuer)
4 - UFP TECHNOLOGIES INC (0000914156) (Issuer)
4 - UFP TECHNOLOGIES INC (0000914156) (Issuer)
4 - UFP TECHNOLOGIES INC (0000914156) (Issuer)
4 - UFP TECHNOLOGIES INC (0000914156) (Issuer)
4 - UFP TECHNOLOGIES INC (0000914156) (Issuer)
Live finance-specific insights
NEWBURYPORT, Mass., Aug. 04, 2025 (GLOBE NEWSWIRE) -- UFP Technologies, Inc. (NASDAQ:UFPT), a contract development and manufacturing organization that specializes in single-use and single-patient medical devices, today reported net income of $17.2 million or $2.21 per diluted common share outstanding for its second quarter ended June 30, 2025, compared to net income of $13.6 million or $1.75 per diluted common share outstanding for the same quarter in 2024. Adjusted earnings per diluted common share outstanding grew 27% to $2.50. Sales for the second quarter were $151.2 million compared to sales of $110.2 million in the second quarter of 2024. Net income for the six-month period ended June
NEWBURYPORT, Mass., July 29, 2025 (GLOBE NEWSWIRE) -- UFP Technologies, Inc. (NASDAQ:UFPT), a contract development and manufacturing organization that specializes in single-use and single-patient medical devices, today announced the Company plans to report financial results for the second quarter ended June 30, 2025 on August 4, 2025 after the market close. The Company will hold a conference call to discuss results the following day, August 5th, at 8:30 AM Eastern time. Conference Call Information:Date: Tuesday, August 5, 2025Time: 8:30 AM Eastern TimeParticipants may join the call using the following dial-in numbers: Toll-Free: 1-888-243-4451International: 1-412-542-4135 A live
NEWBURYPORT, Mass., July 17, 2025 (GLOBE NEWSWIRE) -- UFP Technologies, Inc. (NASDAQ:UFPT), a designer and custom manufacturer of comprehensive solutions for medical devices, sterile packaging, and other highly engineered custom products, today announced the acquisitions of Universal Plastics & Engineering Company, Inc. ("UNIPEC") and Techno Plastics Industries, Inc. ("TPI"). These transactions further expand UFP's capabilities in tight tolerance film components and thermoplastic molding for the medical device market. UNIPEC, headquartered in Rockville, Maryland, develops and manufactures precision thermoformed and heat-sealed polymer components used primarily for shielding batteries in C
NEWBURYPORT, Mass., May 06, 2025 (GLOBE NEWSWIRE) -- UFP Technologies, Inc. (NASDAQ:UFPT), a designer and custom manufacturer of comprehensive solutions primarily for the medical market, today reported net income of $17.2 million or $2.21 per diluted common share outstanding for its first quarter ended March 31, 2025, compared to net income of $12.7 million or $1.64 per diluted common share outstanding for the first quarter of 2024. Net Sales for the first quarter were $148.1 million compared to 2024 first quarter sales of $105.0 million. Throughout this news release, reference is made to non-GAAP measures including organic sales growth, adjusted operating income, adjusted SG&A, adjusted n
NEWBURYPORT, Mass., April 30, 2025 (GLOBE NEWSWIRE) -- UFP Technologies, Inc. (NASDAQ:UFPT), an innovative designer and custom manufacturer of components for medical devices, sterile packaging, and other highly engineered products, today announced the Company plans to report financial results for the first quarter ended March 31, 2025 on May 6, 2025 prior to market open. The Company will hold a conference call to discuss results the same day at 10:00 AM Eastern time. Conference Call Information:Date: Tuesday, May 6, 2025Time: 10:00 AM Eastern TimeParticipants may join the call using the following dial-in numbers: Toll-Free: 1-888-243-4451International: 1-412-542-4135 A live webcast of t
NEWBURYPORT, Mass., Feb. 19, 2025 (GLOBE NEWSWIRE) -- UFP Technologies, Inc. (NASDAQ:UFPT), an innovative designer and custom manufacturer of comprehensive solutions for medical devices, sterile packaging and other highly engineered custom products, today announced that the Company plans to report results for the fourth quarter and year-ended December 31, 2024, on Tuesday, February 25th. About UFP Technologies, Inc. UFP Technologies is an innovative designer and custom manufacturer of comprehensive solutions for medical devices, sterile packaging, and other highly engineered custom products. UFP is an important link in the medical device supply chain and a valued outsource partner to man
NEWBURYPORT, Mass., July 16, 2024 (GLOBE NEWSWIRE) -- UFP Technologies, Inc. (NASDAQ:UFPT), a designer and custom manufacturer of comprehensive solutions for medical devices, sterile packaging, and other highly engineered custom products, today announced the acquisition of Welch Fluorocarbon Inc. Founded in 1985 and headquartered in Dover, New Hampshire, Welch Fluorocarbon develops and manufactures thermoformed, and heat sealed implantable medical device components utilizing thin, high-performance films. "Welch Fluorocarbon will bring significant thin film thermoforming capabilities to our expanding MedTech portfolio of technologies and materials," said R. Jeffrey Bailly, chairman and C
NEWBURYPORT, Mass., July 01, 2024 (GLOBE NEWSWIRE) -- UFP Technologies, Inc. (NASDAQ:UFPT), a designer and custom manufacturer of comprehensive solutions for medical devices, sterile packaging, and other highly engineered custom products, today announced the acquisition of AJR Enterprises, LLC. Headquartered in St. Charles, Illinois, with additional manufacturing in the Dominican Republic, AJR Enterprises develops and manufactures single use safe patient handling systems. "We are very excited to add AJR Enterprises' capabilities to our patient surfaces portfolio," said R. Jeffrey Bailly, chairman and CEO of UFP Technologies. "Patient surfaces and transfer devices are a growing market due
NEWBURYPORT, Mass., March 17, 2022 (GLOBE NEWSWIRE) -- UFP Technologies, Inc. (NASDAQ:UFPT), an innovative designer and custom manufacturer of components, subassemblies, products, and packaging primarily for the medical market, today announced the acquisition of Advant Medical Ltd. Founded in 1993 and headquartered in Galway, Ireland, with operations in Costa Rica and partner manufacturing in Mexico, Advant Medical is a developer and manufacturer of Class I, II, and III medical devices and packaging. "We are pleased to be joining forces with Advant, our third major acquisition in six months," said R. Jeffrey Bailly, Chairman and CEO. "It's an excellent cultural and strategic fit that i
NEWBURYPORT, Mass., Dec. 23, 2021 (GLOBE NEWSWIRE) -- UFP Technologies, Inc. (NASDAQ:UFPT), an innovative designer and custom manufacturer of components, subassemblies, products, and packaging primarily for the medical market, today announced the acquisition of DAS Medical, Inc. Founded in 2010 and headquartered in Atlanta, Georgia, with manufacturing in the Dominican Republic, DAS is a medical device contract manufacturer specializing in the design, development and production of single-use surgical equipment covers, robotic draping systems and fluid control pouches. "Adding DAS Medical to the UFP MedTech portfolio is another important step in our growth strategy," said R. Jeffrey Bailly,
Live Leadership Updates
NEWBURYPORT, Mass., Aug. 26, 2024 (GLOBE NEWSWIRE) -- UFP Technologies, Inc. (NASDAQ:UFPT), a designer and custom manufacturer of comprehensive solutions for medical devices, sterile packaging, and other highly engineered custom products, today announced the acquisition of AQF Limited ("AQF Medical"). Headquartered in Navan, Ireland with additional joint venture operations in Singapore, AQF Medical develops and manufactures custom-engineered foam and thermoplastic components used in a wide range of medical devices and packaging. "We are excited about the addition of AQF Medical, our fourth acquisition in the past few months," said R. Jeffrey Bailly, Chairman and CEO of UFP Technologies.
NEWBURYPORT, Mass., July 16, 2024 (GLOBE NEWSWIRE) -- UFP Technologies, Inc. (NASDAQ:UFPT), a designer and custom manufacturer of comprehensive solutions for medical devices, sterile packaging, and other highly engineered custom products, today announced the acquisition of Marble Medical. Founded in 1988 and headquartered in Tallahassee, FL, Marble Medical develops and manufactures adhesive based medical components and single-use devices. "Adding Marble Medical's adhesives expertise is a great complement to our surgical robot drapes and stick to skin device platforms," said R. Jeffrey Bailly, chairman and CEO of UFP Technologies. "Marble Medical is a 3M Preferred Converter, and along wi
DURHAM, N.C., March 21, 2024 (GLOBE NEWSWIRE) -- Chimerix (NASDAQ:CMRX), a biopharmaceutical company whose mission is to develop medicines that meaningfully improve and extend the lives of patients facing deadly diseases, today announced the appointment of Marc D. Kozin as the newest member of the Company's Board of Directors. In addition, Patrick Machado has announced his retirement from the Chimerix Board effective at the Company's 2024 Annual Meeting of Stockholders in June, after ten years of service. "We are pleased to welcome Marc to the Board of Directors. Marc's strategic insights and leadership will undoubtedly contribute to the continued growth and success of Chimerix as we wo
NEWBURYPORT, Mass., Feb. 06, 2024 (GLOBE NEWSWIRE) -- UFP Technologies, Inc. (NASDAQ:UFPT), an innovative designer and custom manufacturer of components, subassemblies, products, and packaging primarily for the medical market, today announced the appointment of Mitchell Rock as President of the Company. Rock has been serving as President of the Company's MedTech business. R. Jeffrey Bailly will continue in his capacity as Chairman and Chief Executive Officer. "Mitch has been an extremely valuable member of our management team for over 25 years, most recently very successfully leading our MedTech group," said Bailly. "He is hard-working, well-known, and well-respected throughout our indust
This live feed shows all institutional transactions in real time.
SC 13G - UFP TECHNOLOGIES INC (0000914156) (Subject)
SC 13G/A - UFP TECHNOLOGIES INC (0000914156) (Subject)
SC 13G - UFP TECHNOLOGIES INC (0000914156) (Subject)
SC 13G/A - UFP TECHNOLOGIES INC (0000914156) (Subject)
SC 13G/A - UFP TECHNOLOGIES INC (0000914156) (Subject)
SC 13G/A - UFP TECHNOLOGIES INC (0000914156) (Subject)
SC 13G/A - UFP TECHNOLOGIES INC (0000914156) (Subject)
SC 13G/A - UFP TECHNOLOGIES INC (0000914156) (Subject)
SC 13G/A - UFP TECHNOLOGIES INC (0000914156) (Subject)
SC 13G - UFP TECHNOLOGIES INC (0000914156) (Subject)
8-K - UFP TECHNOLOGIES INC (0000914156) (Filer)
10-Q - UFP TECHNOLOGIES INC (0000914156) (Filer)
8-K - UFP TECHNOLOGIES INC (0000914156) (Filer)
8-K - UFP TECHNOLOGIES INC (0000914156) (Filer)
8-K - UFP TECHNOLOGIES INC (0000914156) (Filer)
8-K - UFP TECHNOLOGIES INC (0000914156) (Filer)
10-Q - UFP TECHNOLOGIES INC (0000914156) (Filer)
144 - UFP TECHNOLOGIES INC (0000914156) (Subject)
8-K - UFP TECHNOLOGIES INC (0000914156) (Filer)
DEF 14A - UFP TECHNOLOGIES INC (0000914156) (Filer)